Longevity Health Holdings, Inc. financial data

Symbol
XAGE, XAGEW on Nasdaq
Location
2403 Sidney Street, Suite 300, Pittsburgh, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 34.7 % -72.2%
Quick Ratio 10.8 %
Debt-to-equity -167 % -163%
Return On Equity 176 %
Return On Assets -262 % -592%
Operating Margin -551 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.78M shares -91.5%
Common Stock, Shares, Outstanding 1.48M shares -92.9%
Entity Public Float 25.1M USD -84.2%
Common Stock, Value, Issued 148 USD -92.9%
Weighted Average Number of Shares Outstanding, Basic 1.21M shares +75%
Weighted Average Number of Shares Outstanding, Diluted 1.21M shares +75%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.05M USD +3988%
Research and Development Expense 946K USD -35.5%
Selling and Marketing Expense 804K USD +3028%
Operating Income (Loss) -5.79M USD -0.68%
Nonoperating Income (Expense) -1.49M USD +85.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.28M USD +54.3%
Income Tax Expense (Benefit) -97.3K USD
Net Income (Loss) Attributable to Parent -7.19M USD +51.7%
Earnings Per Share, Basic 5 USD/shares +67.4%
Earnings Per Share, Diluted 5 USD/shares +67.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.14M USD -85.7%
Accounts Receivable, after Allowance for Credit Loss, Current 54.5K USD
Inventory, Net 1.17M USD +930%
Other Assets, Current 17.6K USD
Assets, Current 3.24M USD -21%
Property, Plant and Equipment, Net 118K USD -20.5%
Operating Lease, Right-of-Use Asset 343K USD -55%
Goodwill 19.3M USD
Assets 3.72M USD -26.1%
Accounts Payable, Current 4.59M USD +12.1%
Accrued Liabilities, Current 2.82M USD +298%
Liabilities, Current 6.91M USD +19.7%
Deferred Income Tax Liabilities, Net 7.84M USD
Operating Lease, Liability, Noncurrent 263K USD -58.1%
Liabilities 7.46M USD +16.4%
Retained Earnings (Accumulated Deficit) -72.3M USD -11%
Stockholders' Equity Attributable to Parent -3.74M USD -172%
Liabilities and Equity 3.72M USD -26.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -753K USD +30%
Net Cash Provided by (Used in) Financing Activities 1.52M USD
Net Cash Provided by (Used in) Investing Activities -150K USD +80%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 1.48M shares -92.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.55M USD -29.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.99K USD -56.8%
Deferred Tax Assets, Valuation Allowance 16.5M USD +35.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.33 pure -90%
Deferred Tax Assets, Gross 16.5M USD +35.8%
Operating Lease, Liability 398K USD -53.1%
Lessee, Operating Lease, Liability, to be Paid 463K USD -54.8%
Property, Plant and Equipment, Gross 863K USD
Operating Lease, Liability, Current 91.5K USD -38.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 116K USD -43.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 116K USD -43.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 65.3K USD -63.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 116K USD -43.5%
Deferred Tax Assets, Operating Loss Carryforwards 8.91M USD +1.54%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 116K USD -43.5%
Operating Lease, Payments 34.8K USD +10.9%
Additional Paid in Capital 68.5M USD +7.57%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.14K USD +0.44%
Depreciation, Depletion and Amortization 82.6K USD -12%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 761K USD +12.7%
Interest Expense 22.2K USD -21.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%